Director of Mobile Imaging Core and Clinical Cognitive Neuroscience

Kent A. Kiehl, Ph.D. conducts clinical neuroscience research of major mental illnesses, with special focus on criminal psychopathy, substance abuse, and psychotic disorders (i.e. schizophrenia). Dr. Kiehl uses non-invasive techniques for measuring brain function, including event-related potentials (ERPs) and functional magnetic resonance imaging(fMRI).

Research Scientist

Rex Jung Ph.D. studies both brain disease and what the brain does well – a field of research known as “Positive Neuroscience”. His research interests focus upon the structural and biochemical correlates of intelligence, creativity and positive affect, particularly white matter contributions to higher cognitive functioning in the normal human brain.

Director of Image Analysis of MR Research

Vince Calhoun, Ph.D. develops techniques for making sense of complex brain imaging data. Because each imaging modality has limitations, the integration of these data is needed to understand the healthy and especially the disordered human brain.

Director of Neurogenetics Core and CASAA Liaison

Despite our best efforts over the last few decades, currently available treatments for addiction are only modestly effective. My lab has taken a two pronged approach to address the limited effectiveness of current treatments. 

Research Scientist

Andrew Mayer, Ph.D. is primarily interested in studying the effects of attention on brain functioning and how the brain allocates attentional resources to different locations in space. 

Director of MEG/EEG Core

Michael Weisend, Ph.D. investigates the neurophysiology of normal memory and cognitive dysfunction and has done clinical and research work on epilepsy, using magnetoencephalography (MEG) to localize the exact areas of the brain where the epilepsy originates.

Scientific Director

Vince Clark, Ph.D. uses a variety of imaging tools to investigate the basic organizational principles of perception, learning, memory, attention and language in healthy individuals, and also the neural basis of psychiatric disorders such as drug and gambling addiction, antisocial disorders and schizophrenia in an effort to develop better treatments for these disorders.

Director of Neuroinformatics

Jeremy Bockholt is responsible for coordinating the massive amounts of Mind generated neuroinformatics data so that data can be exchanged congruently across platforms with multi-modal capability.

Medical Director

Dr. John Phillips is a licensed physician with responsibility for the safety of all study subjects, as well as ensuring the safety of clinical and research operations.

Research Scientist

Paul Mullins, Ph.D. uses high-field magnetic resonance imaging to measure metabolite changes due to neural activation and central nervous system disorders.

Director of the Clinical Magnetic Resonance Core

Charles Gasparovic, Ph.D. directs clinical imaging operations for Mind. He uses MR spectroscopy brain metabolism in disorders such as traumatic brain injury, myotonic dystrophy, dementia, lupus erythematosus, and schizophrenia.

Research Scientist

Faith Hanlon, Ph.D. specializes in the assessment of limbic function and sensory gating in clinical disorders, such as schizophrenia and temporal-lobe epilepsy.

Research Scientist

Arvind Caprihan, Ph.D. is interested in multivariate statistical methods applied to understanding neuroimaging data from different modalities.

Director, Human Resources

Gretchen Mullen has more than 13 years experience in human resources working for Buffalo General Hospital, Lovelace Health Systems and Tricore Reference Laboratories.

President and CEO

Dr. John Rasure has been president and CEO of the Mind Research Network since 2005. During his relatively short tenure, Dr. Rasure has been instrumental in establishing financial stability and a business strategy that has brought growth and long-term sustainability to the organization.

Chief Operations Officer

Melissa Hilleary offers broad knowledge in operations management gained from more than 26 years of experience working in mid- and executive level management positions at the University of New Mexico (UNM).

BOARD CHAIR

Robert D. Taichert, J.D.
of Counsel, Miller Stratvert Law Offices

Barry Baumel, M.D.
Co-founder, Baumel-Eisner Neuromedical Institute, Inc.

Alan Bishop, Ph.D.
Associate Laboratory Director for Theory, Simulation, and Computation (ADTSC), Los Alamos National Laboratory

W. Ward Davidson
Vice President, TouchTable, Inc. (Retired)

R. Philip Eaton, M.D.
Emeritus Vice President for Health Sciences, University of New Mexico

Laurie Flynn
Director of the Carmel Hill Center for Early Diagnosis and Treatment, Columbia University

Robert Goodman
Vice-Chair, Bank of Albuquerque (Retired)

Jim J. Marquez, J.D.
Attorney (Retired)

Leonard Napolitano, Ph.D.
Dean Emeritus, University of New Mexico School of Medicine

John F. Nash, Jr., Ph.D.
Nobel Laureate in Economics and Senior Research Mathematician, Princeton University

Gwill Newman, B.A.
Author, Humanitarian, Phi Beta Kappa, Vassar

Steven M. Paul, MD
Executive Vice President, Science and Technology
President, Lilly Research Laboratories, Eli Lilly and Company

Gayle M. Pohl, Ph.D., A.P.R.
Associate Professor for Communications Studies, University of Northern Iowa

W. Timothy Pohl, J.D.
Managing Director, Water Utility Advisors

Alton D. Romig Jr., Ph.D.
Senior Vice President/Deputy Laboratories Director Integrated Technologies & Systems,  Sandia National Laboratories

Julie Weaks Gutiérrez, M.B.A.
Executive Vice President, Geolex, Inc.

EX-OFFICIO

John Lauriello, M.D.
Professor, Vice Chair and Chief of Clinical Operations, Department of Psychiatry, University of New Mexico

Yoshio Okada, Ph.D.
Professor of Neurology and Neurosciences and Director, The BRaIN Center, University of New Mexico

Bruce R. Rosen, M.D., Ph.D.
Director, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital

S. Charles Schulz, M.D.
Professor and Head of the Department of Psychiatry, University of Minnesota

Kamil Ugurbil, Ph.D.
Professor of Radiology, Neurosciences and Medicine and Director, Center for Magnetic Resonance Research, University of Minnesota
 

Director, Information Technology

Jeremy Lawrence has spent much of his career working with high performance computing and data mining, in particular at ASIC chipmaker Paracel, a Celera Genomics company, the firm that privately sequenced the human genome.

Research Scientist 

Julia M. Stephen, Ph.D., specializes in MEG research investigating both sensory and cognitive functioning, including basic functioning of the visual system as well as clinical research to identify early markers of neural dysfunction.